Adenovirus-based Vaccines and Therapies with Integrated AI, IoT, and Nanomaterials

The present inventive concept integrates adenovirus vectors derived from chimpanzee adenovirus with advanced technologies such as AI, IoT, blockchain, and nanomaterials to create a new generation of vaccines and therapies with enhanced efficacy, personalization, and real-time monitoring capabilities.

Traditional vaccine development has been limited by the lack of effective vectors, inadequate personalization, and insufficient monitoring capabilities. The original patent disclosed adenovirus vectors derived from chimpanzee adenovirus, which have shown promise but still have limitations. The present inventive concept addresses these limitations by combining the adenovirus vectors with advanced technologies to create a more powerful system.

The inventive concept comprises adenovirus vectors derived from chimpanzee adenovirus, which are integrated with AI-powered genomics analysis tools for identifying optimal vaccine candidates, blockchain-secured genomic data for secure and transparent data management, IoT-enabled lab automation for streamlined vector production, and nanomaterial-based delivery systems for enhanced vaccine efficacy. The system enables real-time monitoring of vaccine efficacy through IoT-enabled sensor networks and provides personalized medicine through AI-driven molecular modeling and machine learning-based prediction of immunogenicity.

The integration of adenovirus vectors with AI, IoT, blockchain, and nanomaterials is novel and non-obvious compared to the original patent, which only disclosed adenovirus vectors. The inventive concept's synergistic combination of these technologies provides a new and innovative solution for vaccine development and therapy.

Alternative embodiments of the inventive concept may include the use of different adenovirus vectors, alternative AI algorithms, or various nanomaterials for delivery. Variations may also include the integration of additional technologies such as CRISPR gene editing or synthetic biology.

The inventive concept has significant commercial potential in the vaccine and therapy markets, particularly in the areas of personalized medicine, infectious disease treatment, and cancer therapy. The integration of advanced technologies provides a competitive advantage and enables the development of more effective and targeted treatments.